Centene Corporation

CEO Sarah London has driven a modernization and simplification agenda and is recognized externally, but 2025 events exposed execution risk in Marketplace forecasting and rate assumptions. The CFO team has improved cash discipline and portfolio focus versus the prior era.

Insider alignment has been incremental; notably the CEO made an open-market purchase in Q3 2025 while buybacks have reduced diluted shares outstanding materially since 2021. Governance and disclosure around risk-adjustment assumptions are adequate, and Medicare Stars are on a gradual improvement path from a low base.

Overall, capable team navigating a difficult 2025; credibility needs rebuilding via consistent underwriting results in 2026.